Vinorelbine in Treating Older Women With Stage IV Breast Cancer

Phase 2 Completed 25 enrolled Alliance for Clinical Trials in Oncology National Cancer Institute (NCI) · collab

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of vinorelbine in treating older women who have stage IV breast cancer.

Timeline

Start: 2001-11
Primary completion: 2006-03
Completion: 2007-08

Publications

Results Baweja M, Suman VJ, Fitch TR, Mailliard JA, Bernath A, Rowland KM, Alberts SR, Kaur JS, Perez EA; NCCTG. Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG study. Ann Oncol. 2006 Apr;17(4):623-9. doi: 10.1093/annonc/mdj130. Epub 2006 Mar 6.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vinorelbine	Small molecule	70 mg/m2	Oral

Vinorelbine in Treating Older Women With Stage IV Breast Cancer

Summary

Timeline

Publications

Drugs

Indications